Pleuropulmonary Blastoma (PPB) is a rare lung cancer that can be treated with surgery, chemotherapy, or both. In this study, researchers are testing two things:
- For Type I PPB: Comparing surgery alone to surgery with chemotherapy.
- For Type II & III PPB: Adding a drug called Topotecan to the usual chemotherapy to see if it works better.
Key Points:
- Who can join? Children aged 21 or younger with newly diagnosed PPB.
- Study Length: Treatment cycles last about 21 days each, with check-ups every 3-6 months after treatment, lasting up to 5 years.
- Potential Risks: Participants may experience side effects from chemotherapy, and pregnant girls cannot join due to risks to the baby.
By joining, patients help researchers understand better ways to treat PPB. Different treatments are tested based on the PPB type. Blood and tumor samples are needed for study purposes. The study is crucial for finding safer and more effective treatments for children with PPB.
How understandable was the trial content above?
Hard to understand
Easy to understand